CEO Update: August 2021

CEO Update: August 2021

InSitu Biologics has had a very productive summer. We received positive pre-clinical animal study results on our lead product, had positive regulatory interactions with the FDA, further developed our manufacturing capabilities, and made progress towards future funding...